Beranda › Gangguan Tidur › Florida
Uji klinis Gangguan Tidur di Florida
6 studi untuk Gangguan Tidur mencari peserta di lokasi di Florida.
Kota di Florida
Teks studi resmi (Bahasa Inggris)
A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
- DM Clinical Research, Bradenton
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07823608A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
- Brandon, Florida, Brandon
- Miami, Florida, Miami
- Miami, Florida, Miami
- dan 4 lainnya
Menerima pesertaFase 2/3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07598708A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)
- Alkermes Investigational Site, Brandon
- Alkermes Investigational Site, Miami
- Alkermes Investigational Site, Winter Park
Menerima pesertaFase 3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07540897A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Alkermes Investigational Site, Brandon
- Alkermes Investigational Site, Miami
- Alkermes Investigational Site, Winter Park
Menerima pesertaFase 3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07455383A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
- Alkermes Investigational Site, Brandon
- Alkermes Investigational Site, Maimi
- Alkermes Investigational Site, Winter Park
Menerima pesertaFase 3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07502443A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Alkermes Investigational Site, Brandon
- Alkermes Investigational Site, Miami
- Alkermes Investigational Site, Winter Park
Menerima pesertaFase 2/3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT06767683Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.